Skip to main content

Advertisement

Table 1 Baseline characteristics of patients

From: Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar

  Treatment group
Parameters CQ AQ SP AQ+SP AQ+AS
No. of patients 42 39 40 83 83
No. females (%) 20 (47.6%) 22 (56.4%) 26 (65.0%) 42 (50.6%) 38 (46.3%)
Mean age (months. range) 3.8 (0.6–14) 3.3 (0.7–13) 3.8 (0.5–12) 3.9 (0.8–15) 3.9 (0.5–15)
Mean weight (kg. range) 12.9 (7–35) 13.0 (7.8–40) 12.1 (6–34) 14.3 (7–50) 14.6 (6–54.5)
Mean temperature (°C. range) 38.4 (37.5–40.4) 38.4 (37.5–40.8) 38.5 (37.5–40.8) 38.6 (37.5–41.0) 38.6 (37.5–40.9)
Geometric mean parasite density (/μl. range) 21156 (1020–199058) 25559 (1142–199800) 25640 (1010–199531) 22368 (1050–199048) 22905 (1005–184881)
Previous antimalrial therapy (%) 2 (4.7%) 1 (2.9%) 2 (5.0%) 2 (3.9%) 3 (5.3%)
Mean haemoglobin (g/dl. range) 10.1 (6.2–14.0) 10.0 (6.4–14.2) 9.7 (6.2–12.4) 10.2 (6.2–15.6) 10.4 (6.2–15.5)
  1. CQ. Chloroquine; AQ. Amodiaquine; SP. Sulphadoxine-pyrimethamine; AS. artesunate.